News
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.
FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...
Tonight’s the premiere of Dimension 20’s steampunk-themed Cloudward, Ho! series. I’m excited; anyone else? (If you’re ...
The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...
The agency has provided few details about its AI pilot as it makes moves on its “aggressive timeline” for rollout.
Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...
The FDA launched Elsa, its first generative AI tool, to streamline reviews and modernize agency workflow across all centers.
The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...
The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results